{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"336","upperLimit":"561","value":"434"},{"groupId":"OG001","lowerLimit":"49","upperLimit":"105","value":"71"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"37"},{"groupId":"OG001","value":"33"}],"units":"Participants"}],"title":"Age<24 years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"361","upperLimit":"645","value":"482"},{"groupId":"OG001","lowerLimit":"61","upperLimit":"174","value":"104"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"31"},{"groupId":"OG001","value":"27"}],"units":"Participants"}],"title":"Age>=24 years"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"385","upperLimit":"583","value":"473"},{"groupId":"OG001","lowerLimit":"63","upperLimit":"118","value":"86"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"51"}],"units":"Participants"}],"title":"Baseline HIV viral load <=75"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"226","upperLimit":"587","value":"365"},{"groupId":"OG001","lowerLimit":"21","upperLimit":"260","value":"75"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"}],"units":"Participants"}],"title":"Baseline HIV viral load >75"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"354","upperLimit":"638","value":"475"},{"groupId":"OG001","lowerLimit":"59","upperLimit":"163","value":"98"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"20"}],"units":"Participants"}],"title":"Baseline CD4 <=500"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"347","upperLimit":"571","value":"445"},{"groupId":"OG001","lowerLimit":"53","upperLimit":"117","value":"78"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"44"},{"groupId":"OG001","value":"40"}],"units":"Participants"}],"title":"Baseline CD4 >500"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"351","upperLimit":"626","value":"469"},{"groupId":"OG001","lowerLimit":"57","upperLimit":"133","value":"87"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"31"}],"units":"Participants"}],"title":"Nadir CD4 <=350"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"344","upperLimit":"594","value":"452"},{"groupId":"OG001","lowerLimit":"50","upperLimit":"134","value":"82"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"28"}],"units":"Participants"}],"title":"Nadir CD4>350"}],"denoms":[{"counts":[{"groupId":"OG000","value":"68"},{"groupId":"OG001","value":"60"}],"units":"Participants"}],"description":"Geometric mean concentration of antibodies for HPV 11 at 7 and 24 months","dispersionType":"95% Confidence Interval","groups":[{"description":"Month 7 visit after enrollment","id":"OG000","title":"Month 7 Visit"},{"description":"Month 24 visit after enrollment","id":"OG001","title":"Month 24 Visit"}],"paramType":"GEOMETRIC_MEAN","populationDescription":"Eligible participants who received at least one vaccination and who were sero-negative for HPV 11 at baseline with evaluable serum assessments.","reportingStatus":"POSTED","timeFrame":"at 7 and 24 Months","title":"Geometric Mean Titers for HPV 11 According to Participant Age, HIV Viral Load, CD4+ T Cell Count, and Nadir CD4 Level","type":"SECONDARY","unitOfMeasure":"mMU/mL"}